Skip to main content
CRMD logo
CRMD
(NASDAQ)
CorMedix Inc.
$7.05-- (--)
Loading... - Market loading

CorMedix (CRMD) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

CorMedix Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for CorMedix Inc. (CRMD) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents144.8440.6543.6443.1553.3241.9116.5317.6210.38
Short-Term Investments3.6911.0432.3915.6412.154.4411.980.001.60
Cash & Short-Term Investments148.5351.6976.0358.7965.4746.3528.5117.6211.98
Accounts Receivable171.2351.650.000.000.050.000.000.010.06
Inventory29.727.602.110.000.000.140.340.430.59
Other Current Assets7.863.390.880.620.771.410.500.600.63
Total Current Assets367.05114.5879.4559.5566.4748.1829.3518.6713.27
Non-Current Assets
Property, Plant & Equipment (Net)8.982.322.512.382.371.130.130.160.19
Goodwill30.000.000.000.000.000.000.000.000.00
Intangible Assets379.071.840.000.000.000.000.000.000.00
Other Non-Current Assets0.420.110.100.100.100.000.000.000.00
Total Non-Current Assets459.094.272.612.492.481.130.130.160.19
Total Assets826.14118.8582.0662.0468.9549.3129.4818.8313.45
Current Liabilities
Accounts Payable7.881.724.282.202.211.131.022.591.81
Short-Term Debt1.450.170.150.130.240.110.000.000.00
Accrued Liabilities148.3629.956.973.973.012.920.000.000.00
Deferred Revenue0.000.000.000.000.000.000.000.010.09
Other Current Liabilities3.022.006.973.972.892.924.805.174.36
Total Current Liabilities174.2733.8411.406.315.354.165.837.776.26
Non-Current Liabilities
Long-Term Debt144.630.350.520.670.800.920.006.130.00
Other Non-Current Liabilities99.100.000.000.000.000.000.000.000.00
Total Non-Current Liabilities246.570.350.520.670.800.920.006.130.00
Total Liabilities420.8434.1911.926.986.155.095.8313.896.26
Stockholders' Equity
Common Stock0.080.060.050.040.040.030.030.110.07
Retained Earnings-176.58-339.63-321.70-275.36-245.66-217.45-195.42-178.99-152.17
Accumulated Other Comprehensive Income0.000.090.090.080.090.100.100.100.10
Additional Paid-in Capital581.80424.13391.69330.29308.33261.54218.94183.72159.20
Shares Outstanding79.2664.4154.9442.8238.090.000.000.000.00
Total Stockholders' Equity405.3184.6670.1455.0662.8044.22-195.42-178.99-152.17
Total Liabilities & Equity826.14118.8582.0662.0468.9549.3129.4818.8313.45

Frequently Asked Questions About CorMedix Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is CRMD's debt level?

Review CorMedix's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.